Outperform On ZOLL Medical
We retain our Outperform recommendation on resuscitation devices maker ZOLL Medical (NASDAQ:ZOLL) following its forecast-topping first-quarter fiscal 2012 results. Revenues and earnings for the quarter beat the Zacks Consensus Estimates driven by strong sales from the company’s LifeVest and temperature management businesses. ZOLL Medical registered healthy sales across the North American hospital and pre-hospital markets. [...]
We retain our Outperform recommendation on resuscitation devices maker ZOLL Medical (NASDAQ:ZOLL) following its forecast-topping first-quarter fiscal 2012 results. Revenues and earnings for the quarter beat the Zacks Consensus Estimates driven by strong sales from the company’s LifeVest and temperature management businesses. ZOLL Medical registered healthy sales across the North American hospital and pre-hospital markets.
Revenues in the North American hospital market jumped 12% year over year in … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards